|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women显示文摘 | N. Pedersen A. Bortoli D. Duricova R. D′Inca M. R. Panelli J. P. Gisbert G. Zoli A. López‐Sanromán F. Castiglione G. Riegler V. Annese P. Gionchetti A. Prada E. D. Pont A. Timmer C. Felley M. Shuhaibar E. V. Tsianos C. Dejaco F. J. Baert T. Jess M. Lebech | 2013 | Aliment Pharmacol Ther2013，，5： | 2 |
| 2 | 显示文摘 | Kim H R Jessing J R Parker D L | 1999 | J Vac Sci Technol B1999，17，2： | 1 |
| 3 | 显示文摘 | Jessing J R Parker D L Weichold M H | 1996 | J Vac Sci Technol B1996，14，3： | 1 |
| 4 | Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo 显示文摘 | Jesse J Smith Renee Deehan Kenney David J Gagne Brian P Frushour William Ladd Heidi L Galonek Kristine Israelian Jeffrey Song Giedre Razvadauskaite Amy V Lynch David P Carney Robin J Johnson Siva Lavu Andre Iffland Peter J Elliott Philip D Lambert Keith O Elliston Michael R Jirousek Jill C Milne and Olivier Boss | 2009 | BMC Systems Biology2009，284，27： | 1 |
| 5 | ACCF 2012expert consensus document on practical clinical considerations in the interpretation of troponin elevations:a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents显示文摘 | Newby L K Jesse R L Babb J D | 2012 | J Am Coll Cardiol2012，60，23： | 1 |
| 6 | Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A national survey and case-vignette study显示文摘BACKGROUND Splanchnic vein thrombosis(SVT)is a major complication of moderate and severe acute pancreatitis.There is no consensus on whether therapeutic anticoagulation should be started in patients with acute pancreatitis and SVT.AIM To gain insight into current opinions and clinical decision making of pancreatologists regarding SVT in acute pancreatitis.METHODS A total of 139 pancreatologists of the Dutch Pancreatitis Study Group and Dutch Pancreatic Cancer Group were approached to complete an online survey and case vignette survey.The threshold to assume group agreement was set at 75%.RESULTS The response rate was 67%(n=93).Seventy-one pancreatologists(77%)regularly prescribed therapeutic anticoagulation in case of SVT,and 12 pancreatologists(13%)for narrowing of splanchnic vein lumen.The most common reason to treat SVT was to avoid complications(87%).Acute thrombosis was the most important factor to prescribe therapeutic anticoagulation(90%).Portal vein thrombosis was chosen as the most preferred location to initiate therapeutic anticoagulation(76%)and splenic vein thrombosis as the least preferred location(86%).The preferred initial agent was low molecular weight heparin(LMWH;87%).In the case vignettes,therapeutic anticoagulation was prescribed for acute portal vein thrombosis,with or without suspected infected necrosis(82%and 90%),and thrombus progression(88%).Agreement was lacking regarding the selection and duration of long-term anticoagulation,the indication for thrombophilia testing and upper endoscopy,and about whether risk of bleeding is a major barrier for therapeutic anticoagulation.CONCLUSION In this national survey,the pancreatologists seemed to agree on the use of therapeutic anticoagulation,using LMWH in the acute phase,for acute portal thrombosis and in the case of thrombus progression,irrespective of the presence of infected necrosis. | Noor J Sissingh Jesse V Groen Hester C Timmerhuis Marc G Besselink Bas Boekestijn Thomas L Bollen Bert A Bonsing Frederikus A Klok Hjalmar C van Santvoort Robert C Verdonk Casper H J van Eijck Jeanin E van Hooft Jan Sven D Mieog | 2023 | World Journal of Gastroenterology2023，29，21： | 1 |
| 7 | In- hibition of hemoglobin-mediated lipid oxidation in washed fish muscle by cranberry components 显示文摘 | CHEN-HSIEN L CHRISTIAN G K JESS D R | 2006 | Food Chem2006，99，： | 1 |
| 8 | Adding value to spatially managed inputs by understanding site-specific yield response 显示文摘 | DAVID S B JESS L D SCOTT M S | 2002 | Agricultural Economics2002，27，3： | 1 |
| 9 | National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics & utilization of biochemical markers in acute coronary syndromes显示文摘 | Morrow D A Cannon C P Jesse R L | 2007 | Clin Chem2007，53，： | 1 |
| 10 | Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up显示文摘 | Teri A Longacre Jesse K McKenney Henry D Tazelaar Richard L Kempson Michael R Hendrickson | 2005 | The American Journal of Surgical Pathology2005，，6： | 1 |
| 11 | Li-ion battery shut-off at high temperature caused by polymer phase separation in responsive electrolytes显示文摘 | JESSE C K NICHOLAS L D Mark E R | 2015 | Chemical Communication2015，51，： | 1 |
| 12 | Temperature- dependent development of the mountain pine beetle ( Coleoptera, Seolytidae) and simulation of its phenology显示文摘 | BARBARA J B JESSE A L GENE D A | 1991 | Can Entomol1991，123，5： | 1 |
| 13 | Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial显示文摘 | William D Schweickert Mark C Pohlman Anne S Pohlman Celerina Nigos Amy J Pawlik Cheryl L Esbrook Linda Spears Megan Miller Mietka Franczyk Deanna Deprizio Gregory A Schmidt Amy Bowman Rhonda Barr Kathryn E McCallister Jesse B Hall John P Kress | 2009 | 2009 (9678)2009，，9678： | 1 |
| 14 | Consequences of More Extreme Precipitation Regimes for Terrestrial Ecosystems显示文摘 | Knapp Alan K Beier Claus Briske David D Classen Aimée T Luo Yiqi Reichstein Markus Smith Melinda D Smith Stanley D Bell Jesse E Fay Philip A Heisler Jana L Leavitt Steven W Sherry Rebecca Smith Benjamin Weng Ensheng | 2008 | Bioscience2008，，9： | 1 |
| 15 | National Academy of Clinical Biochemistry Laboratory medicine guidelines:clinical characteristics and utilization of biochemical markers in acute coronary syndromes显示文摘 | Morrow D A Cannon C P Jesse R L | 2007 | Clin Chem2007，115，4： | 1 |
| 16 | An international survey of classification and treatment choices for group D retinoblastoma显示文摘AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region.METHODS: An anonymized electronic survey was offered to 115 physicians at 39 retinoblastoma centers worldwide asking about IIRC classification schemes and treatment patterns used between 2008 and 2012. Participants were asked to record which version of the IIRC was used for classification, how many group D eyes were diagnosed, and how many eyes were treated with enucleation versus globe salvaging therapies. Averages of eyes per treatment modality were calculated and stratified by both IIRC version and geographic region. Statistical significance was determined by Chi-square, ANOVA and Kruskal-Wallis tests using Prism.RESULTS: The survey was completed by 29% of physicians invited to participate. Totally 1807 D eyes were diagnosed. Regarding IIRC system, 27% of centers used the Children's Hospital of Los Angeles(CHLA) version, 33% used the Children's Oncology Group(COG) version, 23% used the Philadelphia version, and 17% were unsure. The rate for primary enucleation varied between 0 and 100% and the mean was 29%. By IIRC version, primary enucleation rates were: Philadelphia, 8%; COG, 34%; and CHLA, 37%. By geographic region, primary enucleation rates were: Latin America, 57%; Asia, 40%; Europe, 36%; Africa, 10%, US, 8%; and Middle East, 8%. However, systemic chemoreduction was used more often than enucleation in all regions except Latin America with a mean of 57% per center(P<0.0001). CONCLUSION: Worldwide there is no consensus on which IIRC version is used, systemic chemoreduction was the most frequently used initial treatment during the study period followed by enucleation and primary treatment modality, especially enucleation, varied greatly with regards to IIRC version used and geographic region. | Christina Scelfo Jasmine H Francis Vikas Khetan Thomas Jenkins Brian Marr David H Abramson Carol L Shields Jacob Pe’er Francis Munier Jesse Berry J.William Harbour Andrey Yarovoy Evandro Lucena Timothy G Murray Pooja Bhagia Evelyn Paysse Samuray Tuncer Guillermo L Chantada Annette C Moll Tatiana Ushakova David A Plager Islamov Ziyovuddin Carlos A Leal Miguel A Materin Xun-Da Ji Jose W Cursino Rodrigo Polania Hayyam Kiratli Charlotta All-Ericsson Rejin Kebudi Santosh G Honavar Vicktoria Vishnevskia-Dai Sidnel Epelman Anthony B Daniels Jeanie D Ling Fousseyni Traore Marco A Ramirez-Ortiz | 2017 | International Journal of Ophthalmology(English edition)2017，10，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员